Predict ADME parameters from molecular structure, combine in vitro P-CAB proton inhibition data, build PBPK-PD model to simulate intragastric pH curves, realize early human PK/PD assessment at preclinical stage.
B²O Pharmaceuticals is an innovative pharmaceutical research and development company dedicated to artificial intelligence (AI)-driven clinical pharmacology and quantitative pharmacology.